Zika vaccine shows promise in early human trial

Zika vaccine shows promise in early human trial

A DNA-based Zika vaccine from Inovio Pharmaceuticals Inc and South Korea’s GeneOne Life Science Inc induced anti-Zika immune responses in an early stage human trial, U.S. researchers reported on Wednesday.

2
Like
Save

Comments

Comments are disabled for this post.